Company Filing History:
Years Active: 2023-2025
Title: The Innovative Contributions of Adrienne Li
Introduction
Adrienne Li is a prominent inventor based in Cambridge, MA, known for her significant contributions to the field of biotechnology. With a focus on immunogenic compositions, she has developed innovative solutions aimed at treating diseases associated with anaplastic lymphoma kinase (ALK).
Latest Patents
Adrienne Li holds two patents that showcase her groundbreaking work. Her latest patents include "ALK polypeptides and methods of use thereof," which features immunogenic compositions containing ALK polypeptides. These compositions and methods are designed to treat diseases associated with ALK in subjects, particularly cancers such as solid tumor cancers or ALK+ cancers.
Career Highlights
Li's career is marked by her role at Elicio Therapeutics, Inc., where she applies her expertise in developing therapeutic solutions. Her work has the potential to make a significant impact on cancer treatment, reflecting her dedication to advancing medical science.
Collaborations
Throughout her career, Adrienne has collaborated with notable colleagues, including Jackson Eby and Peter C Demuth. These partnerships have further enhanced her research and development efforts in the field.
Conclusion
Adrienne Li's innovative work in the biotechnology sector, particularly her patents related to ALK polypeptides, underscores her role as a leading inventor. Her contributions are paving the way for new treatments in cancer therapy, highlighting the importance of her research in improving patient outcomes.